AbbVie to acquire Allergan for $63bn
rafapress / Shutterstock.com
Allergan has struck a deal with two generic manufacturers to resolve a long-running patent infringement suit over its antidepressant drug Fetzima (Levomilnacipran).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, Fetzima, US District Court for the District of New Jersey, MSN Laboratories, Aurobindo Pharma, generics